On the brink: Why slashing spending on global health will make us all sicker
This week, the Chancellor received a letter from those who know the NHS inside out with a plea to think again about international aid.
It was signed by Presidents of diaspora health associations from across the UK, representing thousands of overseas-born healthcare workers serving in our NHS. Their message was clear: if the UK retreats further from its global health commitments, we all lose.
These are not lobbyists or idealists. They're doctors, nurses and specialists on the front line of British healthcare. They understand the hard economics of government budgets. But they also understand something the Treasury may be in danger of missing: global health isn't charity. It's a vital investment in our own safety, economy and NHS resilience.
When the UK backs health partnerships abroad, it's not altruism. Helping others stay healthy is one of the smartest ways to protect ourselves. Programmes like the Commonwealth Partnerships for Antimicrobial Stewardships funded by DHSC's Fleming fund, link NHS teams with hospitals in low-and middle-income countries to tackle antimicrobial resistance. So far, more than 65,000 health workers have been trained. Prescribing has improved. Infection controls are stronger.
Meanwhile, UK staff return with invaluable experience that strengthens our NHS, from leadership under pressure to a deeper understanding of infectious diseases. It's the kind of low cost, high impact intervention any sensible government should double down on.
Before the 2021 cuts, a programme called the UK Partnerships for Health Systems was set to train 78,000 global healthcare workers and improve care for hundreds of thousands of patients. It was abruptly slashed by £48million. Programmes were halted. Partnerships paused. Opportunities for mutual learning lost. That was the last government. We did not expect to see the same thing happen under this government, with its distinguished track-record of supporting UK Aid over many decades.
The letter from the Presidents of Diaspora Associations makes it clear what this means in real terms – not just for patients in low-income countries, but for UK health care workers whose knowledge and innovation stem from these international exchanges.
One in five NHS workers is a non-UK national. Their expertise connects the UK to over 200 health systems worldwide. They help make the NHS one of the most internationally engaged healthcare systems on the planet. Many trained in countries with fragile systems. Many are already playing leadership roles in linking British institutions with their counterparts overseas.
In Tanzania, a partnership led by Northumbria Healthcare NHS Trust helped introduce laparoscopic surgery and set up a burns unit. In Ethiopia, Nottingham's NHS trust collaborated with Jimma University to improve trauma and diabetes care. The return on investment? More skilled, confident UK staff - and stronger UK healthcare at home.
Health partnerships do far more than train workers. They help develop curricula, fortify health systems overseas and importantly, build Britain's global reputation at a time when influence is in short supply. The UK-Africa Health Summit earlier this year showed the power of collaboration, bringing together Ministers, health leaders and diaspora professionals to forge solutions on workforce mobility and pandemic preparedness.
This diplomacy is with a scalpel, not a sword – and it works.
The Chancellor faces tough choices. But cutting the global health budget and not mitigating the consequences, would be a false economy. It would weaken our defences against future pandemics, shrink the NHS's talent pipeline and damage our standing in the world.
As the letter from diaspora leaders makes clear: this is not a plea for charity. It's a call for strategic investment.
Let's not wait for the next global crisis to remind us that disease doesn't respect borders. Let's act now – to protect the NHS, promote economic stability and ensure Britain remains a trusted force for health and progress worldwide.
Ben Simms is CEO of Global Health Partnerships (formerly THET)
Protect yourself and your family by learning more about Global Health Security
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Why Greif Stock Triumphed on Thursday
The company published its second earnings release of the current fiscal year. This pleased investors largely because of a sizable earnings beat. 10 stocks we like better than Greif › Veteran industrial company Greif (NYSE: GEF) was a standout on the stock exchange Thursday. Investors, captivated by a very convincing earnings beat in the company's freshly reported second quarter of fiscal 2025, pushed the industrial packing specialist's share price up by nearly 16%. In doing so, Greif not only crushed the S&P 500 index's performance on the day (it landed in the red by 0.5%), but also that of many blue chip stocks. Greif published those quarterly results just after market close on Wednesday, divulging that its net sales inched up by 1% on a year-over-year basis to hit nearly $1.39 billion. The dynamic was similar on the bottom line, with GAAP net income bumping 0.5% higher to $54.5 million, or $1.22 per share. Although the consensus analyst estimate for revenue was higher, at $1.42 billion, pundits tracking the stock underestimated profitability. Collectively, they were anticipating Greif would only earn $1.12 per share in net income. In its earnings release, Greif management indicated a steady-as-she-goes approach to its business. It quoted CEO Ole Rosgaard as saying that "The resilience of our results, supported by deliberate portfolio moves and operational discipline, demonstrates that Greif is well-positioned for success and value creation now and in the future." Greif cautiously proffered selected guidance for the entirety of this fiscal year, raising the low end of its projection for non-GAAP (adjusted) earnings before interest, taxes, depreciation, and amortization (EBITDA) to $725 million and its adjusted free cash flow to $280 million. Both estimates compare positively to the actual fiscal 2024 results of $694 million and just under $190 million, respectively. Greif isn't the most exciting company on the scene, but at times, it's the unexciting businesses that produce the most dependably pleasing results. This one does what it does well, and what's more it knows how to keep its investors happy with a relatively high-yield dividend. I think it' s a fine stock to own, even after the post-earnings pop. Before you buy stock in Greif, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Greif wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor's total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Greif Stock Triumphed on Thursday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Trump's trade talk delegation is set to face off with China's negotiators in London. Here is what's at stake.
Top Trump officials are meeting Chinese negotiators in London on Monday. This would be the first official US-China talk since a temporary tariff truce on May 12. International trade experts have said that Trump could be under pressure to strike a deal. Three top Trump administration economic officials will face off against Chinese negotiators in a renewed effort to break the US-China trade deadlock. Secretary of the Treasury Scott Bessent, Secretary of Commerce Howard Lutnick, and Trade Representative Jamieson Greer will be meeting China's delegation in London on Monday. "The meeting should go very well," President Donald Trump wrote in a social media post announcing the talks. This coming meeting will be the first official talk between the two countries since they mutually lowered tariffs in a temporary truce on May 12, after talks in Geneva. The renewed talks follow a 90-minute phone call between Trump and China's leader Xi Jinping on Thursday, a rare direct conversation that Trump later described as "very good." According to Trump, the two leaders also agreed to visit each other in person, without providing more details in terms of a timeline. The Chinese Embassy of Washington did not respond to a request for who would be attending this negotiation from its side. The team they sent to Geneva consisted of Vice Premier He Lifeng, Vice Commerce Minister Li Chenggang, and Vice Finance Minister Liao Min. Notably, Li has a Master of Laws from the University of Hamburg in Germany and has been part of China's delegation to the World Trade Organization since 2021. International trade experts previously told Business Insider that much is at stake for both China and the US to strike a deal, or at the very least, continue the truce beyond August 12 when the 90-day tariff pause will expire. "The Trump administration made their job harder because the tariff policies they've implemented are costly to Americans and American companies, and therefore, the market doesn't like it," said Philip Luck, director of the CSIS Economics Program. "They are under a lot of pressure to do things fast." Meanwhile, a lawsuit that threatens to undo all of Trump's tariffs enacted under the IEEPA also looms over negotiations with China. Drew DeLong, lead in geopolitical dynamics practice at Kearney, a global strategy and management consulting firm, told BI that if the court strikes down tariffs before trade deals could come to pass, other routes of imposing tariffs could be more complicated and time-consuming. The White House did not provide Business Insider with any additional comment beyond Trump's Truth Social post. Read the original article on Business Insider

2 hours ago
US, Chinese officials to meet in London next week for new round of trade talks
WASHINGTON -- Senior U.S. administration officials will meet with a Chinese delegation on Monday in London for the next round of trade negotiations between Washington and Beijing, President Donald Trump said Friday. The meeting comes after a phone call between Trump and Chinese leader Xi Jinping on Thursday, which the U.S. president described as a 'very positive' conversation as the two countries attempt to break an impasse over tariffs and global supplies of rare earth minerals. Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick and U.S. Trade Representative Jamieson Greer will represent the U.S. side in the trade talks. 'The meeting should go very well,' Trump wrote on his social media platform Friday afternoon. Speaking to reporters on Air Force One Friday, Trump said Xi had agreed to restart exports of rare earth minerals and magnets to the U.S. which China had slowed, threatening a range of U.S. manufacturers that relied on the critical materials. The was no immediate confirmation from China. The Thursday conversation between Trump and Xi, who lead the world's two biggest economies, lasted about an hour and a half, according to the U.S. president. The Chinese foreign ministry has said Trump initiated the call. The ministry said Xi asked Trump to 'remove the negative measures' that the U.S. has taken against China. It also said that Trump said 'the U.S. loves to have Chinese students coming to study in America,' although his administration has vowed to revoke some of their visas.